Dermatology - European Medical Journal

Continue

Dermatology

Filter
EMJ
14 Jun 2016

Phase 2a trial of ZPL-3893787 (ZPL-389), a histamine H4 receptor antagonist, for atopic dermatitis

Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, discusses the design and outcomes from a phase 2a proof-of-concept clinical trial…
EMJ
14 Jul 2015

Supporting CKD Patients at Home

Baxter Symposium from the 52nd European Renal Association – European Dialysis and Transplant Association Congress 2015.